Thus, we can propose that the combination of the immunohistochemistry staining of ZEB1 and Tspan8, whose expression is perfectly correlated in cutaneous melanoma patients’ lesions, with stiffness measurement in patients could be a new means to evaluate the dissemination potential of cutaneous melanomas. This evidence concerns the gene ZEB1 and cutaneous melanoma.